Hemodynamic Effects of Combined Focal Cerebral Ischemia and Amyloid Protein Toxicity in a Rat Model: A Functional CT Study

Background/Objective Clinical evidence indicates that cerebral ischemia (CI) and a pathological factor of Alzheimer's disease, the β-amyloid (Aβ) protein, can increase the rate of cognitive impairment in the ageing population. Using the CT Perfusion (CTP) functional imaging, we sought to investigate the interaction between CI and the Aβ protein on cerebral hemodynamics. Methods A previously established rat model of CI and Aβ was used for the CTP study. Iodinated contrast was given intravenously, while serial CT images of sixteen axial slices were acquired. Cerebral blood flow (CBF) and blood volume (CBV) parametric maps were co-registered to a rat brain atlas and regions of interest were drawn on the maps. Microvascular alteration was investigated with histopathology. Results CTP results revealed that ipsilateral striatum of Aβ+CI and CI groups showed significantly lower CBF and CBV than control at the acute phase. Striatal CBF and CBV increased significantly at week 1 in the CI and Aβ+CI groups, but not in the Aβ alone or control group. Histopathology showed that average density of dilated microvessels in the ipsilateral striatum in CI and Aβ+CI groups was significantly higher than control at week 1, indicating this could be associated with hyperperfusion and hypervolemia observed from CTP results. Conclusion These results demonstrate that CTP can quantitatively measure the hemodynamic disturbance on CBF and CBV functional maps in a rat model of CI interacting with Aβ.

[1]  [Amyloid imaging]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.

[2]  E. Fainardi,et al.  Improving Acute Stroke Management with Computed Tomography Perfusion: A Review of Imaging Basics and Applications , 2012, Translational Stroke Research.

[3]  J P B O'Connor,et al.  Dynamic contrast-enhanced imaging techniques: CT and MRI. , 2011, The British journal of radiology.

[4]  P. Mcgeer,et al.  Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain , 2011, International journal of Alzheimer's disease.

[5]  W. Brown,et al.  Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.

[6]  Sterling C. Johnson,et al.  Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[7]  Debashis Mukhopadhyay,et al.  AICD Overexpression in Neuro 2A Cells Regulates Expression of PTCH1 and TRPC5 , 2010, International journal of Alzheimer's disease.

[8]  K. Miles,et al.  Molecular imaging with dynamic contrast-enhanced computed tomography. , 2010, Clinical radiology.

[9]  D. Holtzman,et al.  Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells , 2010, Molecular Neurodegeneration.

[10]  B. Långström,et al.  The use of PET in Alzheimer disease , 2010, Nature Reviews Neurology.

[11]  S. de Santi,et al.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.

[12]  J. Detre,et al.  Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[13]  Norbert Schuff,et al.  Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging , 2009, Alzheimer's & Dementia.

[14]  W. Klunk,et al.  Update on amyloid imaging: From healthy aging to Alzheimer’s disease , 2009, Current neurology and neuroscience reports.

[15]  H. Soininen,et al.  Focal cerebral ischemia in rats alters APP processing and expression of Aβ peptide degrading enzymes in the thalamus , 2009, Neurobiology of Disease.

[16]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[17]  Yaakov Stern,et al.  Contribution of vascular risk factors to the progression in Alzheimer disease. , 2009, Archives of neurology.

[18]  L. White Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. , 2009, Journal of Alzheimer's disease : JAD.

[19]  Rachel L. Mistur,et al.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  David C. Alsop,et al.  Hippocampal hyperperfusion in Alzheimer's disease , 2008, NeuroImage.

[21]  R. Pluta,et al.  Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease , 2008, Neuropsychiatric Disease and Treatment.

[22]  Michael Oliver Flüß,et al.  Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging , 2008, NeuroImage.

[23]  F. Leblhuber,et al.  Value of cerebral blood flow quantification in the diagnosis of dementia , 2008, Nuclear medicine communications.

[24]  J. C. Torre,et al.  Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease , 2008, Neurodegenerative Diseases.

[25]  V. Hachinski,et al.  Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid , 2007, Stroke.

[26]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[27]  Kwang-Soo Lee,et al.  Clinical Significance of Silent Cerebral Infarctions in Patients With Alzheimer Disease , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[28]  M. D'Andrea,et al.  Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons , 2007, Brain Research.

[29]  Simon A. Moss,et al.  b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease , 2007 .

[30]  C. Ballard,et al.  Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia , 2006, Neuropathology and applied neurobiology.

[31]  F. Donnerstag,et al.  Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease , 2006, European Radiology.

[32]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[33]  J. Gore Lifetime Risk for Stroke , 2006 .

[34]  Hiroshi Matsuda,et al.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.

[35]  Emmanuel L Barbier,et al.  Comparative Overview of Brain Perfusion Imaging Techniques , 2005, Journal of neuroradiology. Journal de neuroradiologie.

[36]  Sanjeet Pakrasi,et al.  Emission tomography in dementia. , 2005, Nuclear medicine communications.

[37]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[38]  V. Hachinski,et al.  Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: Inflammatory Responses , 2005, Stroke.

[39]  E. Larson,et al.  Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study , 2004, Journal of the American Geriatrics Society.

[40]  M. A. Bell,et al.  Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities , 1981, Acta Neuropathologica.

[41]  F. Crawford,et al.  Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. , 2003, Neurological research.

[42]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[43]  Tohru Shiga,et al.  Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. , 2003, AJNR. American journal of neuroradiology.

[44]  N. Patel,et al.  Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature , 2002, Annals of the New York Academy of Sciences.

[45]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[46]  R. Kauppinen,et al.  β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Kauppinen,et al.  Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Ohnishi,et al.  Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion Spect the Recruitment Was For , 2000 .

[49]  M. Breteler Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study , 2000, Annals of the New York Academy of Sciences.

[50]  J. Shi,et al.  Hypoperfusion induces overexpression of β-amyloid precursor protein mRNA in a focal ischemic rodent model , 2000, Brain Research.

[51]  R. Craen,et al.  Dynamic CT measurement of cerebral blood flow: a validation study. , 1999, AJNR. American journal of neuroradiology.

[52]  Fiona Crawford,et al.  Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo , 1998, Neuroscience Letters.

[53]  R. Mohs,et al.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.

[54]  C. Iadecola,et al.  Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.

[55]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[56]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[57]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[58]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[59]  T Nariai,et al.  Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. , 1995, AJNR. American journal of neuroradiology.